EFPIA MAPPS Newsletter
View past EFPIA MAPPS newsletters here.
Newsletter October 2016
In this newsletter we look forward to the EMA Patient Registries Workshop to be held on 28 October 2016 at the EMA offices in London. The workshop is designed to bring together multiple stakeholders including registry owners, industry, HTA representatives and regulators to discuss the challenges and barriers to collaboration and identify specific solutions.
Newsletter August 2016
In this newsletter we cover the The DIA 2016 Session ”Europe and the US: Making Outcomes-Based Health Care Possible”. On 29 June 2016, key stakeholders and decision-makers in the field of real-world evidence met to take part in the DIA 2016 seminar “Europe and the US: Making Outcomes-Based Health Care Possible”. As Europe and the US continue to examine ways to develop therapies on the basis of their “real world” performances, the session aimed to discuss benefits and challenges of outcomes-based health care, as well as the remaining barriers to implementation.
Newsletter June 2016
Featuring an editorial from Dr Sarah Garner, on how changes in technology allow initiatives like ADAPT SMART to pave the way for MAPPs; also featuring a review from Luk Maes, Executive Director Scientific Policies Europe, Bristol-Myers Squibb, Belgium, on the DIA Hamburg 2016 panel “MAPPs: The IMI ADAPT SMART Project”.
Newsletter March 21, 2016
In this newsletter, Marshall L. Summar, MD speaks on the role of MAPPs in the rare disease space. Dr Summar is co-chair of the rare disease advisory panel of Patient-Centered Outcomes Research Institute (PCORI) and the Scientific Advisory Committee of the National Organization for Rare Diseases (NORD). He is one of the world’s leading authorities on accelerated pathways in orphan diseases and the uses of Real World Evidence in pediatric clinical research. A series of MAPPs-related articles provides additional infor the potential of adaptive pathways and explore the need for a “sea change” in drug development.
Newsletter March 3, 2016
In this newsletter, Susan Forda of Eli Lilly writes on what sets PRIME apart from similar initiatives with the same aim, while also looking at the progress that has been made in efforts to advance access to innovative therapies thus far.
Newsletter November – December 2015
Featuring the event report and video footage from “Better Science, Better Health: New Healthcare Models”, the EFPIA-supported conference in Washington D.C. EFPIA MAPPs was represented by Sabina Atzor, Director Regulatory Affairs, part-time seconded from F.Hoffmann-La Roche to EFPIA.
Newsletter September – October 2015
Featuring the event report and video footage from “New Paths to Personalised Medicine – A Live Webstream from the European Health Forum Gastein”, and an interview with Sabine Atzor, Director Regulatory Affairs, part-time seconded from F.Hoffmann-La Roche to EFPIA.
Newsletter July 2015
Featuring an interview with Amy Miller, Executive VP of the Personalized Medicine Coalition.
Newsletter June 2015
Featuring event report and video footage of the event “MAPPS: Saving Time, Saving Lives”, which was organised as part of the 2015 EFPIA General Assembly.
Newsletter May 2015
Featuring an interview with Sarah Garner, Association Director for Science Policy and Research at NICE.
Newsletter April 2015
Featuring an interview with Professor Luca Pani, Director General of the Italian Medicines Agency.
Newsletter March 2015
Featuring an interview with Bettina Ryll, Founder of Melanoma Patient Network Europe.